168 related articles for article (PubMed ID: 38175345)
21. Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy.
Reis J; Boavida J; Tran HT; Lyngra M; Reitsma LC; Schandiz H; Melles WA; Gjesdal KI; Geisler J; Geitung JT
BMC Cancer; 2022 Jun; 22(1):702. PubMed ID: 35752785
[TBL] [Abstract][Full Text] [Related]
22. Progress in the surgical management of breast cancer: Present and future.
Morrow M
Breast; 2015 Nov; 24 Suppl 2():S2-5. PubMed ID: 26249120
[TBL] [Abstract][Full Text] [Related]
23. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
24. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
[TBL] [Abstract][Full Text] [Related]
25. Preoperative (neoadjuvant) systemic treatment of breast cancer.
Kaufmann M; von Minckwitz G; Rody A
Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
[TBL] [Abstract][Full Text] [Related]
26. De-escalation of breast and axillary surgery in exceptional responders to neoadjuvant systemic treatment.
Heil J; Pfob A; Morrow M
Lancet Oncol; 2021 Apr; 22(4):435-436. PubMed ID: 33794203
[No Abstract] [Full Text] [Related]
27. Controversies in Breast Cancer Surgery.
Gutnik L; Fayanju OM
Surg Clin North Am; 2021 Dec; 101(6):1033-1044. PubMed ID: 34774266
[TBL] [Abstract][Full Text] [Related]
28. Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.
Di Micco R; Gentilini OD
Minerva Chir; 2020 Dec; 75(6):392-399. PubMed ID: 33345525
[TBL] [Abstract][Full Text] [Related]
29. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
30. Axillary surgery in breast cancer: An updated historical perspective.
Magnoni F; Galimberti V; Corso G; Intra M; Sacchini V; Veronesi P
Semin Oncol; 2020 Dec; 47(6):341-352. PubMed ID: 33131896
[TBL] [Abstract][Full Text] [Related]
31. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
32. Ongoing clinical trials on axillary management.
Kouloura A; Lanitis S; Filopoulos E; Angelopoulos MP; Kosmidis SP; Arkadopoulos N
Minerva Chir; 2020 Dec; 75(6):408-418. PubMed ID: 33345527
[TBL] [Abstract][Full Text] [Related]
33. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Kuerer HM; Newman LA; Smith TL; Ames FC; Hunt KK; Dhingra K; Theriault RL; Singh G; Binkley SM; Sneige N; Buchholz TA; Ross MI; McNeese MD; Buzdar AU; Hortobagyi GN; Singletary SE
J Clin Oncol; 1999 Feb; 17(2):460-9. PubMed ID: 10080586
[TBL] [Abstract][Full Text] [Related]
34. De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
de Wild SR; Simons JM; Vrancken Peeters MTFD; Smidt ML; Koppert LB
Breast Care (Basel); 2021 Dec; 16(6):584-589. PubMed ID: 35087361
[TBL] [Abstract][Full Text] [Related]
35. Breast surgery after neoadjuvant therapy.
Gnant M
Curr Opin Oncol; 2022 Nov; 34(6):643-646. PubMed ID: 36083127
[TBL] [Abstract][Full Text] [Related]
36. Tailored axillary surgery - A novel concept for clinically node positive breast cancer.
Heidinger M; Knauer M; Tausch C; Weber WP
Breast; 2023 Jun; 69():281-289. PubMed ID: 36922305
[TBL] [Abstract][Full Text] [Related]
37. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
38. Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy.
García-Calvo L; Martí Álvarez C; Gutiérrez AH; García AB; Muñoz RA; Sánchez-Méndez JI
Clin Breast Cancer; 2023 Aug; 23(6):672-679. PubMed ID: 37331894
[TBL] [Abstract][Full Text] [Related]
39. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients.
Boersma LJ; Mjaaland I; van Duijnhoven F
Breast; 2023 Apr; 68():181-188. PubMed ID: 36805769
[TBL] [Abstract][Full Text] [Related]
40. Neo-Adjuvant chemotherapy and its affects to the axilla-Can we safely downgrade axillary surgery to mirror the approach in the breast.
Batt J; Chambers A; Al-Allak A; Vestey S; Hunt R; Massey E; Fowler C
Breast J; 2020 Sep; 26(9):1667-1672. PubMed ID: 32767467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
